News6 days agoThe Night of Vision 2024: A Spotlight on Usher SyndromeThe annual La Nit de la Visió event, organized by Save Sight Now Europe,…
News6 days agoBreakthrough in USH1B Research: Advancing MYO7A Therapy DevelopmentUnderstanding MYO7A to Advance USH1B Therapies The goal of this project is twofold: 1.…
News4 months agoSpain Releases First Report on Rare Visual DiseasesRetina Murcia Association launches with its Research Group on Rare Visual Diseases (GISERV) the…
News4 months agoWe attended EURETINA 2024 in BarcelonaSave Sight Now Europe attended Euretina’24 in Barcelona from 19-22nd of September It was…
News4 months agoCollaborative Visit at L’Institut de la Vision, ParisSave Sight Now Europe joined the team at L’Institut de la Vision, Paris, to…
News4 months agoAAVantgarde Announces LUCE-1 Trial for Usher Syndrome Type 1B – First Patient DosedAAVantgarde Announces LUCE-1 Trial for Usher Syndrome Type 1B and First Patient Dosed AAVantgarde…
News7 months agoRIWC 2024 (Retina International World Congress)Championing Usher Syndrome: Highlights from RIWC24 in Dublin We are thrilled to share our…
News9 months agoARVO 2024 (The Association for Research in Vision and Ophthalmology Conference)Save Sight Now Europe has been at ARVO 2024 to Champion Advances in Retinal…
News9 months agoAAVantgarde Bio Unveils LUCE-1 Clinical Trial Design for Usher Syndrome type 1B Gene TherapyAAVantgarde Bio Unveils Innovative LUCE-1 Clinical Trial Design (for USH1B) at Gene Therapy Summit…
News10 months agoRestoring hearing loss – leading advancement in OTOF gene-related deafnessFirst gene therapy treatment for a hereditary form of deafness in the USA The…